SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Zebra 365 who wrote (4237)1/3/1998 1:05:00 PM
From: DR. BOND  Respond to of 23519
 
Zebra.....Fine Job on your explanation of SHORTING!

Thank You!

DB



To: Zebra 365 who wrote (4237)1/3/1998 4:14:00 PM
From: hal jordan  Read Replies (1) | Respond to of 23519
 
Zebra, its incredible how many shorts there are out there. Either somebody knows something we don't (cause at 11+ there's not much room to go down and I can think of higher priced shorts).

If we get good news (puleeeeze) imagine what a short squeeze can bring us to:)

Hal



To: Zebra 365 who wrote (4237)1/3/1998 4:21:00 PM
From: Evan Dimmer  Read Replies (1) | Respond to of 23519
 
As the earnings report rapidly approaches, would someone be able to review for me (and others) what the analysts predict for the 4Q and yearly earnings. Also, what have been the past predictions from this thread. Yahoo gives a .25 estimate, has this been updated since the announcement?

I see NO PROBLEM getting .20 in the 4Q, giving it $1.06 for the full year. I sure hope that this guess is on the low side.

I have heard people say that analysts are going rediculously low with 4Q earnings, so VVUS will be able to have an upside surprise. Is this true, could someone help me with this?

Thanks in advance.

Ed



To: Zebra 365 who wrote (4237)1/3/1998 11:05:00 PM
From: LoLoLoLita  Read Replies (2) | Respond to of 23519
 
Zebra,

Thank You for your good summary of short sale info. If you
can't answer the following question, maybe someone else can:

When shares are "borrowed from another customer" does that
other customer forfeit the right to vote at the shareholder
meeting? Only 33 M or so shares are authorized to vote.
But (counting the "phantom shares") we had 43 M shares out
as of 12/15.

Also, I want to add to your post that in addition to being
liable for any dividends, the shorts are liable for any
warrants, rights, etc. issued by the company (e.g., the
"poison pill" distribution that is already authorized by Vivus
in case of a takeover attempt). It is my understanding that
if such a distribution were to occur, the shorts would have
to purchase those rights on the open market in order to
"make whole" the buyer of the shares that they sold short.

David